Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NoDoubt: Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management
NCT07682558Phase 3Not yet recruiting
- Sponsor
- University Hospital Basel
- Start
- Oct 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 3 trial of Metamizole sodium, ibuprofen in cancer pain, sponsored by University Hospital Basel. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Metamizole sodiumibuprofen
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT07682558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682558.